Advocacy at a Glance STEVEN GROSSMAN 12/17/21 Advocacy at a Glance STEVEN GROSSMAN 12/17/21 Califf hearing moves process forward; status of appropriations and reconciliation Read More Advocacy at a Glance STEVEN GROSSMAN 12/10/21 Advocacy at a Glance STEVEN GROSSMAN 12/10/21 Senate logjam is easing, fate of pending legislation uncertain; Califf confirmation hearing Read More Advocacy at a Glance STEVEN GROSSMAN 12/3/21 Advocacy at a Glance STEVEN GROSSMAN 12/3/21 New FY 22 CR extends to February 18; Medical device cybersecurity: a matter of concern. Read More Advocacy at a Glance STEVEN GROSSMAN 11/19/21 Advocacy at a Glance STEVEN GROSSMAN 11/19/21 Legislative Update; Upcoming Alliance Webinar. Read More Advocacy at a Glance STEVEN GROSSMAN 11/12/21 Advocacy at a Glance STEVEN GROSSMAN 11/12/21 Legislative Update; Safer Food Supply Basics: Whole Genome Sequencing Read More Advocacy at a Glance STEVEN GROSSMAN 11/5/21 Advocacy at a Glance STEVEN GROSSMAN 11/5/21 Sunset Rule Withdrawn; CBER’s Dr. Peter Marks Pens OP-ED on What Regulators Must Learn from COVID-19 Read More Advocacy at a Glance STEVEN GROSSMAN 10/29/21 Advocacy at a Glance STEVEN GROSSMAN 10/29/21 FDA May Gain $300 Million for Infrastructure from House Reconciliation Bill; Update on Status of FY 22 FDA Appropriations Read More Advocacy at a Glance STEVEN GROSSMAN 10/22/21 Advocacy at a Glance STEVEN GROSSMAN 10/22/21 Senate Labor-HHS funding Bill has several FDA references; bipartisan House Members urges USDA and FDA to cooperate on animal genetics Read More Advocacy at a Glance STEVEN GROSSMAN 10/15/21 Advocacy at a Glance STEVEN GROSSMAN 10/15/21 A Funding Reprieve Via CR, but Challenges Ahead;Next Steps in the Executive Branch’s Shaping of Possible ARPA-H Read More Advocacy at a Glance STEVEN GROSSMAN 10/8/21 Advocacy at a Glance STEVEN GROSSMAN 10/8/21 Temporary Truce in the Budget/Debt Limit Wars; FY 22 Appropriations Bills Still Hostage. Read More Advocacy at a Glance STEVEN GROSSMAN 10/1/21 Advocacy at a Glance STEVEN GROSSMAN 10/1/21 Continuing Resolution prevent shutdown, but delays decisions; ARPA-H is a work in progress Read More Advocacy at a Glance STEVEN GROSSMAN 9/24/21 Advocacy at a Glance STEVEN GROSSMAN 9/24/21 Shutdown possible; Updates on food safety and OTC monographs Read More Advocacy at a Glance STEVEN GROSSMAN 9/17/21 Advocacy at a Glance STEVEN GROSSMAN 9/17/21 FY 22 Continuing Resolution (CR) up next; best scenario for FDA; FDA aided by Reconciliation if it passes Read More Advocacy at a Glance STEVEN GROSSMAN 9/10/21 Advocacy at a Glance STEVEN GROSSMAN 9/10/21 Potential for a long endgame on appropriations; A government shutdown is highly unlikely, but not unimaginable. Read More Advocacy at a Glance STEVEN GROSSMAN 9/3/21 Advocacy at a Glance STEVEN GROSSMAN 9/3/21 House/Senate Appropriations have finished Ag/FDA funding, long end game lies ahead; FDA Rulemaking Authority restored, Sunset Rule delayed Read More Advocacy at a Glance Lisa Ellington 8/27/21 Advocacy at a Glance Lisa Ellington 8/27/21 Items for when Congress returns in late August Read More Advocacy at a Glance Lisa Ellington 8/20/21 Advocacy at a Glance Lisa Ellington 8/20/21 Items for when Congress returns in late August Read More Advocacy at a Glance 6/4/21 Advocacy at a Glance 6/4/21 The Alliance applauds the President’s proposed increase of $343 million in FDA’s BA budget. The Senate Agriculture-FDA Appropriations Subcommittee set its FDA budget hearing for June 10. Read More Advocacy at a Glance 5/28/21 Advocacy at a Glance 5/28/21 The President’s FY 22 Budget is being released on May 28. An analysis of the FDA request will be provided to Alliance members following our internal review. Read More Advocacy at a Glance 5/21/21 Advocacy at a Glance 5/21/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More Newer Posts Older Posts
Advocacy at a Glance STEVEN GROSSMAN 12/17/21 Advocacy at a Glance STEVEN GROSSMAN 12/17/21 Califf hearing moves process forward; status of appropriations and reconciliation Read More
Advocacy at a Glance STEVEN GROSSMAN 12/10/21 Advocacy at a Glance STEVEN GROSSMAN 12/10/21 Senate logjam is easing, fate of pending legislation uncertain; Califf confirmation hearing Read More
Advocacy at a Glance STEVEN GROSSMAN 12/3/21 Advocacy at a Glance STEVEN GROSSMAN 12/3/21 New FY 22 CR extends to February 18; Medical device cybersecurity: a matter of concern. Read More
Advocacy at a Glance STEVEN GROSSMAN 11/19/21 Advocacy at a Glance STEVEN GROSSMAN 11/19/21 Legislative Update; Upcoming Alliance Webinar. Read More
Advocacy at a Glance STEVEN GROSSMAN 11/12/21 Advocacy at a Glance STEVEN GROSSMAN 11/12/21 Legislative Update; Safer Food Supply Basics: Whole Genome Sequencing Read More
Advocacy at a Glance STEVEN GROSSMAN 11/5/21 Advocacy at a Glance STEVEN GROSSMAN 11/5/21 Sunset Rule Withdrawn; CBER’s Dr. Peter Marks Pens OP-ED on What Regulators Must Learn from COVID-19 Read More
Advocacy at a Glance STEVEN GROSSMAN 10/29/21 Advocacy at a Glance STEVEN GROSSMAN 10/29/21 FDA May Gain $300 Million for Infrastructure from House Reconciliation Bill; Update on Status of FY 22 FDA Appropriations Read More
Advocacy at a Glance STEVEN GROSSMAN 10/22/21 Advocacy at a Glance STEVEN GROSSMAN 10/22/21 Senate Labor-HHS funding Bill has several FDA references; bipartisan House Members urges USDA and FDA to cooperate on animal genetics Read More
Advocacy at a Glance STEVEN GROSSMAN 10/15/21 Advocacy at a Glance STEVEN GROSSMAN 10/15/21 A Funding Reprieve Via CR, but Challenges Ahead;Next Steps in the Executive Branch’s Shaping of Possible ARPA-H Read More
Advocacy at a Glance STEVEN GROSSMAN 10/8/21 Advocacy at a Glance STEVEN GROSSMAN 10/8/21 Temporary Truce in the Budget/Debt Limit Wars; FY 22 Appropriations Bills Still Hostage. Read More
Advocacy at a Glance STEVEN GROSSMAN 10/1/21 Advocacy at a Glance STEVEN GROSSMAN 10/1/21 Continuing Resolution prevent shutdown, but delays decisions; ARPA-H is a work in progress Read More
Advocacy at a Glance STEVEN GROSSMAN 9/24/21 Advocacy at a Glance STEVEN GROSSMAN 9/24/21 Shutdown possible; Updates on food safety and OTC monographs Read More
Advocacy at a Glance STEVEN GROSSMAN 9/17/21 Advocacy at a Glance STEVEN GROSSMAN 9/17/21 FY 22 Continuing Resolution (CR) up next; best scenario for FDA; FDA aided by Reconciliation if it passes Read More
Advocacy at a Glance STEVEN GROSSMAN 9/10/21 Advocacy at a Glance STEVEN GROSSMAN 9/10/21 Potential for a long endgame on appropriations; A government shutdown is highly unlikely, but not unimaginable. Read More
Advocacy at a Glance STEVEN GROSSMAN 9/3/21 Advocacy at a Glance STEVEN GROSSMAN 9/3/21 House/Senate Appropriations have finished Ag/FDA funding, long end game lies ahead; FDA Rulemaking Authority restored, Sunset Rule delayed Read More
Advocacy at a Glance Lisa Ellington 8/27/21 Advocacy at a Glance Lisa Ellington 8/27/21 Items for when Congress returns in late August Read More
Advocacy at a Glance Lisa Ellington 8/20/21 Advocacy at a Glance Lisa Ellington 8/20/21 Items for when Congress returns in late August Read More
Advocacy at a Glance 6/4/21 Advocacy at a Glance 6/4/21 The Alliance applauds the President’s proposed increase of $343 million in FDA’s BA budget. The Senate Agriculture-FDA Appropriations Subcommittee set its FDA budget hearing for June 10. Read More
Advocacy at a Glance 5/28/21 Advocacy at a Glance 5/28/21 The President’s FY 22 Budget is being released on May 28. An analysis of the FDA request will be provided to Alliance members following our internal review. Read More
Advocacy at a Glance 5/21/21 Advocacy at a Glance 5/21/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More
